Downstream Process Development
We have a proven track record of developing successful downstream processes for multiple biotherapeutics, including: monoclonal antibodies, recombinant proteins, glycoproteins, bacteria, and yeast.
We have optimized our downstream impurity removal processes to minimize steps and maximize yield resulting in cost savings to the customer.
For our microbial processes, we have the ability to purify directly from harvest or to refold proteins from inclusion body preparations.
Additionally, our process development teams are fully integrated with our analytical development teams to ensure we achieve rigorous product quality attributes.